about
Diffuse anterior retinoblastoma: current conceptsAdult onset retinoblastomaChemotherapy in Retinoblastoma: Current ApproachesUS and MRI of pediatric ocular masses with histopathological correlation.Enhanced sensitivity for detection of low-level germline mosaic RB1 mutations in sporadic retinoblastoma cases using deep semiconductor sequencing.Evaluation of Abelmoschus moschatus extracts for antioxidant, free radical scavenging, antimicrobial and antiproliferative activities using in vitro assaysBasic fibroblast growth factor impact on retinoblastoma progression and survivalPharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.Establishment of the relationship between tumor size and range of histological involvement to evaluate the rationality of current retinoblastoma managementProgress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.Quality of life of adult retinoblastoma survivors in the NetherlandsEpidemiology and Rb1 gene of retinoblastoma.Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor modelExpression of C-kit in retinoblastoma: a potential therapeutic target.Current therapy and recent advances in the management of retinoblastoma.Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups.Retinoblastoma in a young adult mimicking Coats' diseaseHealth-related quality of life of child and adolescent retinoblastoma survivors in the Netherlands.Role of B lymphoma Mo-MLV insertion region 1 in the oncogenic behavior of retinoblastomas.Custom ocular prosthesis in rehabilitation of a child operated for retinoblastoma.Cause-specific mortality in long-term survivors of retinoblastoma.Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma.Diffuse anterior retinoblastoma: A review.Effects of NF-κB and hypoxia on the biological behavior of Y79 retinoblastoma cells.The effect of imatinib mesylate on the proliferation, invasive ability, and radiosensitivity of retinoblastoma cell lines.Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model.microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A.Influence of Socioeconomic and Cultural Factors on Retinoblastoma Management.Childhood cancer and developmental biology a crucial partnership.Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma.A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.Expression of multidrug resistance proteins in retinoblastoma.Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India.Effects of miR-22 on viability, migration, invasion and apoptosis in retinoblastoma Y79 cells by targeting high-mobility group box 1
P2860
Q26801127-8421EC36-BC93-4287-900E-969BB4ADEB71Q28069282-1B7D4189-DE1F-42E7-8A51-648CDF8D1FD7Q28075246-32CD92D3-DFFE-4E13-B4C0-646266736074Q30454146-13F0BC90-E230-4C57-99F6-F63C7FF9BD03Q33956073-F66B6233-CB56-40C4-8632-63B7C7B01DBEQ33995187-092D20CA-7086-48F8-A7E0-CF835AE0366BQ34070005-81E77620-FA6F-493C-8640-D36849930EBDQ34422585-940B24B9-733B-44AD-B4C9-AF8452A629F1Q35050530-9C50406A-09D3-44E9-88F6-50B06AEEF32FQ35060311-41AA2D98-43FD-481D-9E6C-171E1AA6740BQ35706804-E1A0C09D-0424-4E3D-A3E0-C43AA51C4E6CQ35846831-22E815A6-F427-4222-BFFB-6C52B0C1BDD4Q35923816-04D7FE87-1D85-4783-9D91-ABA5FD336C90Q35979171-F99CF093-EAFA-4F21-B803-BE41753A367FQ36172104-86B0F4F8-7E96-4596-AF78-5AC0350C8679Q36228138-63A62C1C-172D-4A88-B5AE-5AD5B654604FQ36287393-F5856349-4F70-4F7B-8793-2EF7D324056DQ36358636-D6118608-7DDD-447A-993F-702A2CE0D08BQ36417316-E8555D59-C059-445C-812A-394F647A55F8Q36727745-A7A3924E-5F83-4054-AFA5-E4EE8A7D82D3Q37040971-238C828C-3E93-48A6-B0C4-8B50485C20C5Q37158597-2347769B-E78F-4F7F-9E6E-02163EB7EF10Q37396473-DDC2415F-8EE7-4F23-9F2E-82A12EBCCFE9Q38162437-0C7C5FEC-8094-468B-A6CB-7352EC384053Q38875102-CB8D2EA7-A05B-4124-B182-862342E6F9FFQ39244182-766A657E-7BE3-46FD-8DC2-639C8C591E33Q40007451-D6FAFFB6-AC35-42CD-B627-3C9ED2442F78Q41899216-5BD1821D-01A0-46E8-9C98-2D67532E1325Q42337842-53EAEA53-C310-4C8E-B02D-FDF3F8B9D8D1Q42917104-317DAE4C-89C0-4A5E-839A-DCF7C7BB5505Q43115387-4239160F-4A71-418C-B02B-0F11D863C9E7Q46468588-CF13F669-3EF8-426F-83B5-90D44668ED65Q47115019-DA384035-DFBD-45CB-89C3-820E84303DA8Q49982623-73FE4589-1229-4DF2-9247-973C930A887AQ58597272-931321BA-5E69-4CD0-AA69-EAE80786F73C
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Diagnosis and management of retinoblastoma.
@ast
Diagnosis and management of retinoblastoma.
@en
Diagnosis and management of retinoblastoma.
@nl
type
label
Diagnosis and management of retinoblastoma.
@ast
Diagnosis and management of retinoblastoma.
@en
Diagnosis and management of retinoblastoma.
@nl
prefLabel
Diagnosis and management of retinoblastoma.
@ast
Diagnosis and management of retinoblastoma.
@en
Diagnosis and management of retinoblastoma.
@nl
P2860
P1433
P1476
Diagnosis and management of retinoblastoma.
@en
P2093
Carol L Shields
Jerry A Shields
P2860
P304
P356
10.1177/107327480401100506
P577
2004-09-01T00:00:00Z